Breaking News Instant updates and real-time market news.

PCRX

Pacira

$33.30

3.8 (12.88%)

07:07
04/09/18
04/09
07:07
04/09/18
07:07

Pacira price target raised to $48 from $45 at H.C. Wainwright

H.C. Wainwright analyst Oren Livnat raised his price target for Pacira Pharmaceuticals to $48 after the FDA approved an additional "narrow" nerve block indication for Exparel. The FDA added a specific interscalene brachial plexus block indication for regional anesthesia, effectively an indication for shoulder replacement or rotator cuff repair, Livnat tells investors in a research note. While a broad general nerve block indication would have been best case, and Pacira has to be careful not to promote off-label, this is still an "important positive," the analyst contends. He reiterates a Buy rating on Pacira shares.

  • 16

    Apr

  • 08

    May

PCRX Pacira
$33.30

3.8 (12.88%)

03/21/18
JEFF
03/21/18
NO CHANGE
Target $49
JEFF
Buy
Pacira shares could be positioned for rebound, says Jefferies
Jefferies analyst David Steinberg believes shares of Pacira Pharmaceuticals could be positioned for a rebound after Symphony Health data indicated Exparel posted "well above trend growth" in February. Sales were $24M, up 3.4% from last month and up 12.6% year-over-year, according to Symphony. The data have shown double digit year-over-years gains in four of the past five months, versus just one of nine months prior, Steinberg tells investors in a research note. He believes Pacira is attractively valued at current levels and keeps a Buy rating on the shares with a $49 price target.
04/06/18
WEDB
04/06/18
NO CHANGE
Target $72
WEDB
Outperform
Wedbush says FDA response for Pacira's EXPAREL in nerve block due
Wedbush analyst Liana Moussatos reiterated an Outperform rating and $72 price target on Pacira Pharmaeuticals ahead of the expected PDUFA date for potential expansion of EXPAREL's label to specify nerve block. In a research note to investors, the analyst said she is "hopeful" that EXPAREL could potentially be used to provide improved outcomes in long-acting regional analgesia compared to infusion pumps or opioids. Whether required post-approval or in preparation for future regulatory review, she sees Pacira to continuing to evaluate EXPAREL in different nerve block techniques.
04/09/18
PIPR
04/09/18
NO CHANGE
Target $44
PIPR
Overweight
Piper reiterates Overweight on Pacira after 'watershed' nerve block approval
FDA approval of Pacira Pharmaceuticals' (PCRX) Exparel as a brachial plexus block "is something of a watershed" in that the agency has never before approved any local or regional anesthetic for a single, specific setting, Piper Jaffray analyst David Amsellem tells investors in a research note. He believes the approval suggests an increasingly aggressive FDA approach towards the opioid crisis. Amsellem points out, however, that feedback from his surgeon survey suggests a "strong degree of enthusiasm" for Heron Therapeutics' (HTRX) HTX-011. However, the feedback also indicates that non-opioid, post-operative pain space is not a zero-sum game, the analyst writes. He believes Exparel can grow "even amid greater competition." Amsellem reiterates an Overweight rating on Pacira with a $44 price target.
04/09/18
JPMS
04/09/18
NO CHANGE
JPMS
Neutral
Pacira nerve block approval a 'clear positive,' at JPMorgan
In a research note partially titled "Something's Better Than Nothing," JPMorgan analyst Chris Schott says Friday night's FDA approval for nerve block is a "clear positive" for Pacira Pharmaceuticals. He notes that the Street broadly expected a Complete Response Letter for Exparel in this indication. While the approval does not include a broad nerve block label, it does allow Pacira to target 1M shoulder blocks performed annually, Schott tells investors. However, the Exparel label update also included several failed nerve block studies that should limit off label use of the drug, the analyst adds. He keeps a Neutral rating on Pacira.

TODAY'S FREE FLY STORIES

AGCO

Agco

$57.86

0.5 (0.87%)

09:16
11/21/18
11/21
09:16
11/21/18
09:16
Recommendations
Agco analyst commentary  »

William Blair keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$64.45

-6.3 (-8.90%)

09:15
11/21/18
11/21
09:15
11/21/18
09:15
Recommendations
Kohl's analyst commentary  »

Kohl's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOL

US Ecology

$70.69

-1.29 (-1.79%)

09:11
11/21/18
11/21
09:11
11/21/18
09:11
Hot Stocks
US Ecology sees FY18 at lower end of prior guidance after Grand View explosion »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZOES

Zoe's Kitchen

$12.75

(0.00%)

09:09
11/21/18
11/21
09:09
11/21/18
09:09
Hot Stocks
Breaking Hot Stocks news story on Zoe's Kitchen »

Zoes Kitchen trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLD

Americold Realty Trust

$26.11

-0.27 (-1.02%)

09:05
11/21/18
11/21
09:05
11/21/18
09:05
Recommendations
Americold Realty Trust analyst commentary  »

Americold Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:05
11/21/18
11/21
09:05
11/21/18
09:05
General news
Treasury Action: Treasury yields have slipped from earlier highs »

Treasury Action: Treasury…

TGP

Teekay LNG

$12.79

-0.77 (-5.68%)

09:04
11/21/18
11/21
09:04
11/21/18
09:04
Recommendations
Teekay LNG analyst commentary  »

Teekay LNG price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$149.14

0.46 (0.31%)

09:02
11/21/18
11/21
09:02
11/21/18
09:02
Hot Stocks
Ligand announces OmniAb partnership with iMetabolic Biopharma »

Ligand Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

DE

Deere

$138.49

-4.04 (-2.83%)

, AGCO

Agco

$57.86

0.5 (0.87%)

09:01
11/21/18
11/21
09:01
11/21/18
09:01
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Amazon (AMZN), up…

DE

Deere

$138.49

-4.04 (-2.83%)

AGCO

Agco

$57.86

0.5 (0.87%)

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

FB

Facebook

$132.47

0.85 (0.65%)

FL

Foot Locker

$46.10

-2.69 (-5.51%)

GPS

Gap

$24.65

-0.79 (-3.11%)

ABIL

Ability

$2.83

-0.15 (-5.03%)

ADSK

Autodesk

$122.99

-2.76 (-2.19%)

BZUN

Baozun

$30.07

-0.98 (-3.16%)

BILI

Bilibili

$13.61

0.575 (4.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 26

    Nov

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

09:00
11/21/18
11/21
09:00
11/21/18
09:00
General news
U.S. equities rebounded from correction lows »

U.S. equities rebounded…

TSM

TSMC

$35.64

-0.41 (-1.14%)

, INTC

Intel

$47.38

-0.61 (-1.27%)

08:57
11/21/18
11/21
08:57
11/21/18
08:57
Periodicals
TSMC set to win 'major coup' with IBM server chip deal, Nikkei says »

Well-placed supply chain…

TSM

TSMC

$35.64

-0.41 (-1.14%)

INTC

Intel

$47.38

-0.61 (-1.27%)

IBM

IBM

$117.17

-3.2 (-2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 03

    Mar

TJX

TJX

$46.81

-2.16 (-4.41%)

, BURL

Burlington Stores

$148.36

-8.145 (-5.20%)

08:56
11/21/18
11/21
08:56
11/21/18
08:56
Recommendations
TJX, Burlington Stores analyst commentary  »

TJX apparel category…

TJX

TJX

$46.81

-2.16 (-4.41%)

BURL

Burlington Stores

$148.36

-8.145 (-5.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

DE

Deere

$138.49

-4.04 (-2.83%)

08:55
11/21/18
11/21
08:55
11/21/18
08:55
Technical Analysis
Technical Take: Deere falls after results »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

AAPL

Apple

$177.10

-8.7 (-4.68%)

, BAC

Bank of America

$27.39

-0.375 (-1.35%)

08:55
11/21/18
11/21
08:55
11/21/18
08:55
Options
Notable open interest changes for November 21st »

Tuesday's total…

AAPL

Apple

$177.10

-8.7 (-4.68%)

BAC

Bank of America

$27.39

-0.375 (-1.35%)

GE

General Electric

$7.67

-0.165 (-2.11%)

NVDA

Nvidia

$149.14

4.48 (3.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 10

    Dec

  • 12

    Feb

08:55
11/21/18
11/21
08:55
11/21/18
08:55
General news
The 3k initial claims rise to 224k »

The 3k initial claims…

ROST

Ross Stores

$82.65

-8.54 (-9.37%)

08:51
11/21/18
11/21
08:51
11/21/18
08:51
Recommendations
Ross Stores analyst commentary  »

Ross Stores price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$4.85

-1.04 (-17.66%)

08:50
11/21/18
11/21
08:50
11/21/18
08:50
Downgrade
Limbach Holding rating change  »

Limbach Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

, AAPL

Apple

$177.10

-8.7 (-4.68%)

08:50
11/21/18
11/21
08:50
11/21/18
08:50
Periodicals
Amazon working on getting Amazon Pay into physical stores, WSJ says »

Amazon (AMZN) is working…

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

AAPL

Apple

$177.10

-8.7 (-4.68%)

PYPL

PayPal

$77.76

-2.4 (-2.99%)

WMT

Walmart

$94.21

-2.59 (-2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 18

    Dec

08:50
11/21/18
11/21
08:50
11/21/18
08:50
General news
FX Action: The dollar »

FX Action: The dollar…

08:45
11/21/18
11/21
08:45
11/21/18
08:45
General news
U.S. durable goods orders dropped 4.4% in October »

U.S. durable goods orders…

BGS

B&G Foods

$30.69

0.44 (1.45%)

, GGB

Gerdau

$4.11

-0.19 (-4.42%)

08:45
11/21/18
11/21
08:45
11/21/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BGS

B&G Foods

$30.69

0.44 (1.45%)

GGB

Gerdau

$4.11

-0.19 (-4.42%)

CRON

Cronos Group

$8.19

-0.05 (-0.61%)

QID

ProShares UltraShort QQQ

$46.41

1.57 (3.50%)

SSO

ProShares Ultra S&P 500

$104.01

-4.03 (-3.73%)

NEPT

Neptune Wellness

$3.10

-0.125 (-3.88%)

NFX

Newfield Exploration

$17.67

-1.69 (-8.73%)

CVX

Chevron

$116.19

-3.23 (-2.70%)

EWY

iShares MSCI South Korea Index Fund

$58.89

-1.05 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

08:45
11/21/18
11/21
08:45
11/21/18
08:45
General news
Treasury Action: yields ebbed to lows »

Treasury Action: yields…

08:45
11/21/18
11/21
08:45
11/21/18
08:45
General news
U.S. initial jobless claims rose 3k in the week ended November 17 to 224k »

U.S. initial jobless…

BW

Babcock & Wilcox

$0.90

-0.0052 (-0.58%)

08:41
11/21/18
11/21
08:41
11/21/18
08:41
Conference/Events
Babcock & Wilcox to host conference call »

As previously announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$793.73

-35.77 (-4.31%)

08:40
11/21/18
11/21
08:40
11/21/18
08:40
Recommendations
AutoZone analyst commentary  »

AutoZone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.